Advances in medicine and heroic efforts by the global community have saved millions from death from HIV and other infectious diseases over the past twenty years. Yet that effort, which has been of truly historic proportions, is not enough: the incidence of global cancer is predicted to rise dramatically from 17 million in 2012 to 23.6 million by 2030, and more than 50% of all cancers occur in low and middle-income countries (LMICs) (IARC, 2012). In addition, 65% of all deaths caused by cancer occur in LMICs. Cervical cancer is the most common gynecologic cancer and second most common cancer among women in LMICs. In half of the Sub-Saharan countries, it is the most common women cancer (Denny and Anorlu, 2012) . The prevention, screening, and treatment of cervical cancer in these countries are often impacted by social and economic disparities. Increased efforts dedicated to improving cervical cancer care, education, and research in LMIC are urgently needed.
NCT00193739) comparing neoadjuvant chemotherapy followed by surgery to standard chemoradiation may add new evidence for this treatment strategy.
In the past decade, there are increasing global efforts in the education and training for residents and oncologic surgeons. Novel platforms including online education curriculum and video surgical teachings have been developed to overcome challenges imposed in LMIC which include budget constraints and unstable infrastructures (Autry et al., 2013) . Onsite teaching programs have been developed in LMIC to teach residents on gynecologic oncology (Schmeler et al., 2013; Chuang et al., 2014) . Formal two-year gynecologic oncology fellowship training have recently been developed in Kenya, Ghana and, Ethiopia (Johnston et al., 2017) . The International Gynecologic Cancer Society is developing a larger scale international gynecologic oncology global curriculum and training program for other LMIC (Chuang et al., 2016b) . The curriculum and the scope of training will vary in different regions of the world. Adaption to local cultures is paramount (Johnston et al., 2017) . Equally if not more important in improving cancer care is the development of clinical trials targeted specifically to LMIC. Successes and challenges of conducting clinical trials in LMIC were reported by Grover et al. in this special issue (Grover et al., 2017) . Lastly, it is often observed that clinical presentations and outcomes often appear to be different in LMIC. Whether this is due to social and economic circumstances, biology, or both is unclear; this begs the question of whether diseases require the same treatment in LMIC and they do in HIC. Randall and colleagues (in press) emphasize the importance of research in defining the burden and nature of malignancies in LMIC.
The incidence and mortality of gynecologic cancers will continue to rise in the next decade, with the majority of these new cases occurring in LMIC. Without major efforts to improve screening, treatment, education and research, this trend is expected to continue its current trajectory. Gynecologic Oncology Reports hopes to provide a platform featuring commentary, research and reviews of the current status and provide future directions by global leaders and experts in gynecologic cancers to and from LMIC.
